Effects of severe acute respiratory syndrome (SARS) coronavirus infection on peripheral blood lymphocytes and their subsets.
Identifieur interne : 001101 ( Ncbi/Merge ); précédent : 001100; suivant : 001102Effects of severe acute respiratory syndrome (SARS) coronavirus infection on peripheral blood lymphocytes and their subsets.
Auteurs : Zhongping He [République populaire de Chine] ; Chunhui Zhao ; Qingming Dong ; Hui Zhuang ; Shujing Song ; Guoai Peng ; Dominic E. DwyerSource :
- International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [ 1201-9712 ] ; 2005.
Descripteurs français
- KwdFr :
- Activation des lymphocytes, Adolescent, Adulte, Adulte d'âge moyen, Antigènes CD19 (métabolisme), Femelle, Humains, Lymphopénie, Mâle, Numération des lymphocytes, Rapport CD4-CD8, Récepteurs du fragment Fc des IgG (métabolisme), Sous-populations de lymphocytes (immunologie), Syndrome respiratoire aigu sévère (immunologie), Syndrome respiratoire aigu sévère (physiopathologie), Virus du SRAS (pathogénicité).
- MESH :
- immunologie : Sous-populations de lymphocytes, Syndrome respiratoire aigu sévère.
- métabolisme : Antigènes CD19, Récepteurs du fragment Fc des IgG.
- pathogénicité : Virus du SRAS.
- physiopathologie : Syndrome respiratoire aigu sévère.
- Activation des lymphocytes, Adolescent, Adulte, Adulte d'âge moyen, Femelle, Humains, Lymphopénie, Mâle, Numération des lymphocytes, Rapport CD4-CD8.
English descriptors
- KwdEn :
- Adolescent, Adult, Antigens, CD19 (metabolism), CD3 Complex (metabolism), CD4 Antigens (metabolism), CD4-CD8 Ratio, CD8 Antigens (metabolism), Female, Humans, Leukocyte Common Antigens (metabolism), Lymphocyte Activation, Lymphocyte Count, Lymphocyte Subsets (immunology), Lymphopenia, Male, Middle Aged, Receptors, IgG (metabolism), SARS Virus (pathogenicity), Severe Acute Respiratory Syndrome (immunology), Severe Acute Respiratory Syndrome (physiopathology).
- MESH :
- chemical , metabolism : Antigens, CD19, CD3 Complex, CD4 Antigens, CD8 Antigens, Leukocyte Common Antigens, Receptors, IgG.
- immunology : Lymphocyte Subsets, Severe Acute Respiratory Syndrome.
- pathogenicity : SARS Virus.
- physiopathology : Severe Acute Respiratory Syndrome.
- Adolescent, Adult, CD4-CD8 Ratio, Female, Humans, Lymphocyte Activation, Lymphocyte Count, Lymphopenia, Male, Middle Aged.
Abstract
Severe acute respiratory syndrome (SARS) caused large outbreaks of atypical pneumonia in 2003, with the largest localized outbreak occurring in Beijing, China. Lymphopenia was prominent amongst the laboratory abnormalities reported in acute SARS.
DOI: 10.1016/j.ijid.2004.07.014
PubMed: 16095942
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 002599
- to stream PubMed, to step Curation: 002599
- to stream PubMed, to step Checkpoint: 002737
Links to Exploration step
pubmed:16095942Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Effects of severe acute respiratory syndrome (SARS) coronavirus infection on peripheral blood lymphocytes and their subsets.</title><author><name sortKey="He, Zhongping" sort="He, Zhongping" uniqKey="He Z" first="Zhongping" last="He">Zhongping He</name><affiliation wicri:level="1"><nlm:affiliation>Capital University of Medical Sciences Affiliated Beijing YouAn Hospital, Beijing 100054, PR China. zhongpinghe@yahoo.com</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Capital University of Medical Sciences Affiliated Beijing YouAn Hospital, Beijing 100054</wicri:regionArea><placeName><settlement type="city">Pékin</settlement></placeName></affiliation></author><author><name sortKey="Zhao, Chunhui" sort="Zhao, Chunhui" uniqKey="Zhao C" first="Chunhui" last="Zhao">Chunhui Zhao</name></author><author><name sortKey="Dong, Qingming" sort="Dong, Qingming" uniqKey="Dong Q" first="Qingming" last="Dong">Qingming Dong</name></author><author><name sortKey="Zhuang, Hui" sort="Zhuang, Hui" uniqKey="Zhuang H" first="Hui" last="Zhuang">Hui Zhuang</name></author><author><name sortKey="Song, Shujing" sort="Song, Shujing" uniqKey="Song S" first="Shujing" last="Song">Shujing Song</name></author><author><name sortKey="Peng, Guoai" sort="Peng, Guoai" uniqKey="Peng G" first="Guoai" last="Peng">Guoai Peng</name></author><author><name sortKey="Dwyer, Dominic E" sort="Dwyer, Dominic E" uniqKey="Dwyer D" first="Dominic E" last="Dwyer">Dominic E. Dwyer</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2005">2005</date><idno type="RBID">pubmed:16095942</idno><idno type="pmid">16095942</idno><idno type="doi">10.1016/j.ijid.2004.07.014</idno><idno type="wicri:Area/PubMed/Corpus">002599</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002599</idno><idno type="wicri:Area/PubMed/Curation">002599</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002599</idno><idno type="wicri:Area/PubMed/Checkpoint">002737</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002737</idno><idno type="wicri:Area/Ncbi/Merge">001101</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Effects of severe acute respiratory syndrome (SARS) coronavirus infection on peripheral blood lymphocytes and their subsets.</title><author><name sortKey="He, Zhongping" sort="He, Zhongping" uniqKey="He Z" first="Zhongping" last="He">Zhongping He</name><affiliation wicri:level="1"><nlm:affiliation>Capital University of Medical Sciences Affiliated Beijing YouAn Hospital, Beijing 100054, PR China. zhongpinghe@yahoo.com</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Capital University of Medical Sciences Affiliated Beijing YouAn Hospital, Beijing 100054</wicri:regionArea><placeName><settlement type="city">Pékin</settlement></placeName></affiliation></author><author><name sortKey="Zhao, Chunhui" sort="Zhao, Chunhui" uniqKey="Zhao C" first="Chunhui" last="Zhao">Chunhui Zhao</name></author><author><name sortKey="Dong, Qingming" sort="Dong, Qingming" uniqKey="Dong Q" first="Qingming" last="Dong">Qingming Dong</name></author><author><name sortKey="Zhuang, Hui" sort="Zhuang, Hui" uniqKey="Zhuang H" first="Hui" last="Zhuang">Hui Zhuang</name></author><author><name sortKey="Song, Shujing" sort="Song, Shujing" uniqKey="Song S" first="Shujing" last="Song">Shujing Song</name></author><author><name sortKey="Peng, Guoai" sort="Peng, Guoai" uniqKey="Peng G" first="Guoai" last="Peng">Guoai Peng</name></author><author><name sortKey="Dwyer, Dominic E" sort="Dwyer, Dominic E" uniqKey="Dwyer D" first="Dominic E" last="Dwyer">Dominic E. Dwyer</name></author></analytic><series><title level="j">International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases</title><idno type="ISSN">1201-9712</idno><imprint><date when="2005" type="published">2005</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Antigens, CD19 (metabolism)</term><term>CD3 Complex (metabolism)</term><term>CD4 Antigens (metabolism)</term><term>CD4-CD8 Ratio</term><term>CD8 Antigens (metabolism)</term><term>Female</term><term>Humans</term><term>Leukocyte Common Antigens (metabolism)</term><term>Lymphocyte Activation</term><term>Lymphocyte Count</term><term>Lymphocyte Subsets (immunology)</term><term>Lymphopenia</term><term>Male</term><term>Middle Aged</term><term>Receptors, IgG (metabolism)</term><term>SARS Virus (pathogenicity)</term><term>Severe Acute Respiratory Syndrome (immunology)</term><term>Severe Acute Respiratory Syndrome (physiopathology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Activation des lymphocytes</term><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Antigènes CD19 (métabolisme)</term><term>Femelle</term><term>Humains</term><term>Lymphopénie</term><term>Mâle</term><term>Numération des lymphocytes</term><term>Rapport CD4-CD8</term><term>Récepteurs du fragment Fc des IgG (métabolisme)</term><term>Sous-populations de lymphocytes (immunologie)</term><term>Syndrome respiratoire aigu sévère (immunologie)</term><term>Syndrome respiratoire aigu sévère (physiopathologie)</term><term>Virus du SRAS (pathogénicité)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Antigens, CD19</term><term>CD3 Complex</term><term>CD4 Antigens</term><term>CD8 Antigens</term><term>Leukocyte Common Antigens</term><term>Receptors, IgG</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Sous-populations de lymphocytes</term><term>Syndrome respiratoire aigu sévère</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Lymphocyte Subsets</term><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Antigènes CD19</term><term>Récepteurs du fragment Fc des IgG</term></keywords><keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>SARS Virus</term></keywords><keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr"><term>Virus du SRAS</term></keywords><keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr"><term>Syndrome respiratoire aigu sévère</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>CD4-CD8 Ratio</term><term>Female</term><term>Humans</term><term>Lymphocyte Activation</term><term>Lymphocyte Count</term><term>Lymphopenia</term><term>Male</term><term>Middle Aged</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Activation des lymphocytes</term><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Femelle</term><term>Humains</term><term>Lymphopénie</term><term>Mâle</term><term>Numération des lymphocytes</term><term>Rapport CD4-CD8</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Severe acute respiratory syndrome (SARS) caused large outbreaks of atypical pneumonia in 2003, with the largest localized outbreak occurring in Beijing, China. Lymphopenia was prominent amongst the laboratory abnormalities reported in acute SARS.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">16095942</PMID><DateCompleted><Year>2006</Year><Month>01</Month><Day>05</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1201-9712</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><Issue>6</Issue><PubDate><Year>2005</Year><Month>Nov</Month></PubDate></JournalIssue><Title>International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases</Title><ISOAbbreviation>Int. J. Infect. Dis.</ISOAbbreviation></Journal><ArticleTitle>Effects of severe acute respiratory syndrome (SARS) coronavirus infection on peripheral blood lymphocytes and their subsets.</ArticleTitle><Pagination><MedlinePgn>323-30</MedlinePgn></Pagination><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Severe acute respiratory syndrome (SARS) caused large outbreaks of atypical pneumonia in 2003, with the largest localized outbreak occurring in Beijing, China. Lymphopenia was prominent amongst the laboratory abnormalities reported in acute SARS.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The effect of SARS on peripheral blood lymphocytes and their subsets was examined in 271 SARS coronavirus-infected individuals.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">There was a significant decrease in the CD45+, CD3+, CD4+, CD8+, CD19+ and CD16+/56+ cell counts over the five weeks of the SARS illness although CD4+/CD8+ ratios did not change significantly. The lymphopenia was prolonged, reaching a nadir during days 7-9 in the second week of illness before returning towards normal after five weeks, with the lowest mean CD4+ cell count of 317 cellsx10(6)/L at day 7, and CD8+ cell count of 239 cellsx10(6)/L at day 8. Patients with more severe clinical illness, or patients who died, had significantly more profound CD4+ and CD8+ lymphopenia.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">Lymphopenia is a prominent part of SARS-CoV infection and lymphocyte counts may be useful in predicting the severity and clinical outcomes. Possible reasons for the SARS-associated lymphopenia may be direct infection of lymphocytes by SARS-CoV, lymphocyte sequestration in the lung or cytokine-mediated lymphocyte trafficking. There may also be immune-mediated lymphocyte destruction, bone marrow or thymus suppression, or apoptosis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>He</LastName><ForeName>Zhongping</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Capital University of Medical Sciences Affiliated Beijing YouAn Hospital, Beijing 100054, PR China. zhongpinghe@yahoo.com</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Chunhui</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Qingming</ForeName><Initials>Q</Initials></Author><Author ValidYN="Y"><LastName>Zhuang</LastName><ForeName>Hui</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Shujing</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Guoai</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Dwyer</LastName><ForeName>Dominic E</ForeName><Initials>DE</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2005</Year><Month>08</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>Int J Infect Dis</MedlineTA><NlmUniqueID>9610933</NlmUniqueID><ISSNLinking>1201-9712</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018941">Antigens, CD19</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017252">CD3 Complex</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015704">CD4 Antigens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016827">CD8 Antigens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017452">Receptors, IgG</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.3.48</RegistryNumber><NameOfSubstance UI="D017493">Leukocyte Common Antigens</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018941" MajorTopicYN="N">Antigens, CD19</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017252" MajorTopicYN="N">CD3 Complex</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015704" MajorTopicYN="N">CD4 Antigens</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016516" MajorTopicYN="N">CD4-CD8 Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016827" MajorTopicYN="N">CD8 Antigens</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017493" MajorTopicYN="N">Leukocyte Common Antigens</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008213" MajorTopicYN="N">Lymphocyte Activation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018655" MajorTopicYN="N">Lymphocyte Count</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016131" MajorTopicYN="N">Lymphocyte Subsets</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008231" MajorTopicYN="Y">Lymphopenia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017452" MajorTopicYN="N">Receptors, IgG</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName><QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045169" MajorTopicYN="N">Severe Acute Respiratory Syndrome</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2004</Year><Month>02</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2004</Year><Month>07</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2004</Year><Month>07</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2005</Year><Month>8</Month><Day>13</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2006</Year><Month>1</Month><Day>6</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2005</Year><Month>8</Month><Day>13</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">16095942</ArticleId><ArticleId IdType="pii">S1201-9712(05)00072-X</ArticleId><ArticleId IdType="doi">10.1016/j.ijid.2004.07.014</ArticleId><ArticleId IdType="pmc">PMC7110876</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Infect Dis. 1999 Oct;180(4):950-8</Citation><ArticleIdList><ArticleId IdType="pubmed">10479117</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Nature. 2003 Nov 27;426(6965):450-4</Citation><ArticleIdList><ArticleId IdType="pubmed">14647384</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Clin Diagn Lab Immunol. 2002 Nov;9(6):1392-5</Citation><ArticleIdList><ArticleId IdType="pubmed">12414783</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Pathology. 2003 Dec;35(6):526-31</Citation><ArticleIdList><ArticleId IdType="pubmed">14660106</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Clin Infect Dis. 2003 Apr 15;36(8):985-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12684910</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1977-85</Citation><ArticleIdList><ArticleId IdType="pubmed">12671062</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Clin Infect Dis. 2003 Oct 1;37(7):929-32</Citation><ArticleIdList><ArticleId IdType="pubmed">13130404</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>BMJ. 2003 Jun 21;326(7403):1358-62</Citation><ArticleIdList><ArticleId IdType="pubmed">12816821</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Lancet. 2003 Jul 26;362(9380):263-70</Citation><ArticleIdList><ArticleId IdType="pubmed">12892955</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1953-66</Citation><ArticleIdList><ArticleId IdType="pubmed">12690092</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>JAMA. 2003 Jun 4;289(21):2801-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12734147</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1986-94</Citation><ArticleIdList><ArticleId IdType="pubmed">12682352</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Lancet. 2003 May 24;361(9371):1767-72</Citation><ArticleIdList><ArticleId IdType="pubmed">12781535</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Infect Dis. 2002 May 1;185(9):1338-41</Citation><ArticleIdList><ArticleId IdType="pubmed">12001053</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Clin Diagn Lab Immunol. 2002 Sep;9(5):994-1003</Citation><ArticleIdList><ArticleId IdType="pubmed">12204949</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Pediatrics. 2003 Oct;112(4):e261</Citation><ArticleIdList><ArticleId IdType="pubmed">14523209</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1967-76</Citation><ArticleIdList><ArticleId IdType="pubmed">12690091</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1995-2005</Citation><ArticleIdList><ArticleId IdType="pubmed">12671061</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Epidemiol Infect. 1990 Oct;105(2):435-46</Citation><ArticleIdList><ArticleId IdType="pubmed">2170159</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Lancet. 2003 May 17;361(9370):1701-3</Citation><ArticleIdList><ArticleId IdType="pubmed">12767737</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Pathol. 2004 Jun;203(2):631-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15141377</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Lancet. 2003 Apr 19;361(9366):1319-25</Citation><ArticleIdList><ArticleId IdType="pubmed">12711465</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Clin Diagn Lab Immunol. 2004 Jul;11(4):792-4</Citation><ArticleIdList><ArticleId IdType="pubmed">15242960</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>République populaire de Chine</li></country><settlement><li>Pékin</li></settlement></list><tree><noCountry><name sortKey="Dong, Qingming" sort="Dong, Qingming" uniqKey="Dong Q" first="Qingming" last="Dong">Qingming Dong</name><name sortKey="Dwyer, Dominic E" sort="Dwyer, Dominic E" uniqKey="Dwyer D" first="Dominic E" last="Dwyer">Dominic E. Dwyer</name><name sortKey="Peng, Guoai" sort="Peng, Guoai" uniqKey="Peng G" first="Guoai" last="Peng">Guoai Peng</name><name sortKey="Song, Shujing" sort="Song, Shujing" uniqKey="Song S" first="Shujing" last="Song">Shujing Song</name><name sortKey="Zhao, Chunhui" sort="Zhao, Chunhui" uniqKey="Zhao C" first="Chunhui" last="Zhao">Chunhui Zhao</name><name sortKey="Zhuang, Hui" sort="Zhuang, Hui" uniqKey="Zhuang H" first="Hui" last="Zhuang">Hui Zhuang</name></noCountry><country name="République populaire de Chine"><noRegion><name sortKey="He, Zhongping" sort="He, Zhongping" uniqKey="He Z" first="Zhongping" last="He">Zhongping He</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001101 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 001101 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= pubmed:16095942
|texte= Effects of severe acute respiratory syndrome (SARS) coronavirus infection on peripheral blood lymphocytes and their subsets.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:16095942" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |